Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)

Authors :: Moshe Levy
Nizar Bahlis
Noopur Raje
Caitlin Costello
Bhagirathbhai Dholaria
Melhem Solh
Michael Tomasson
Harman Dube
Michael Damore
Hoi Kei Lon
Cynthia Basu
Athanasia Skoura
Edward Chan
Suzanne Trudel
Andrzej Jakubowiak
Michael Chu
Cristina Gasparetto
Andrew Dalovisio
Michael Sebag
Alexander Lesokhin
Source :: Clinical Lymphoma Myeloma and Leukemia. 21:S252
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Tools